Today in News History
On July 12, several notable moments in the history of News stand out. In 1888, Zygmunt Janiszewski, Polish mathematician and academic (died 1920) was born. In 1949, Rick Hendrick, American businessman, founded Hendrick Motorsports was born. In 1959, Karl J. Friston, English psychiatrist and neuroscientist was born. In 1960, Orlyonok, the main Young Pioneer camp of the Russian SFSR, is founded. In 1985, Ismael Londt, Surinamese-Dutch kickboxer was born. In 1985, Keven Lacombe, Canadian cyclist was born. In 1989, Nick Palmieri, American ice hockey player was born. In 1998, Arkady Ostashev, Soviet/Russian scientist and engineer (born 1925) passed away. In 2013, Amar Bose, American businessman, founded the Bose Corporation (born 1929) passed away. In 2014, Valeriya Novodvorskaya, Russian journalist and politician (born 1950) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.
Novo Nordisk’s owner backs an Italian fund to grow drug startups beyond Denmark
Novo Holdings, the investment company that controls Novo Nordisk and holds the wealth of the Novo Nordisk Foundation, is backing a fund aimed at Italian drug startups, according to Bloomberg. The move extends a pattern that has seen the Danish investor push capital into life sciences hubs well outside Copenhagen, including European deep-tech vehicles backed alongside the [] This story continues at The Next Web
Narrative Intelligence Brief
This article was published by The Next Web, a source frequently categorized with a lean left bias based in Netherlands. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of The Next Web, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.
More from The Next Web
July 11, 2026
The EU says autoplay and infinite scroll are illegal. Meta has until it responds to disagree.
July 11, 2026
OpenAI has folded safety into research again. Its head of safety is leaving.
July 11, 2026
Meta killed its Muse Image AI feature three days after launch. Hollywood had had enough.
July 11, 2026
The US agency that defends federal networks did not have its own incident response playbook when it got hacked
July 11, 2026
Apple sues OpenAI for stealing hardware designs, alleging employees brought prototypes to “show and tell” interviews
Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.More Coverage
Discussion
"england"
Tuchel angry at 'lucky' England - but Bellingham defends players
Tuchel angry at 'lucky' England - but Bellingham defends players
‘A dangerous movie’: Glenn Beck warns ‘Citizen Vigilante’ signals a dark moral shift after Germany bans it
How other outlets are covering this story
Compare narratives across 5 related reports from 5 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.
Coverage bias distribution
5 sources
Left 80%
Center 20%
Right 0%
Foreign Policy Journal
· Jun 21, 2026
Novo Nordisk (NYSE: NVO) Backs DKK 450 Million European Obesity Research Network While Pfizer Advances Monthly GLP-1 Therapy
Novo Nordisk’s (NYSE: NVO) majority owner, the Novo Nordisk Foundation, has launched a large pan-European research initiative targeting obesity and cardiometabolic diseases. The program, called CardioMetabolic Bridge, will commit DKK 450 million over six years to support academic research and company formation across Europe. Early research hubs are being established in London, Italy, and Germany, [] The post Novo Nordisk (NYSE: NVO) Backs DKK 450 Million European Obesity Research Network While Pfizer Advances Monthly GLP-1 Therapy appeared first on Foreign Policy Journal.
The Next Web
· Jul 6, 2026
Skello raises €200M and its founders end up owning more of the company
Most big funding rounds shrink the founders’ slice. Skello’s just grew it. The profitable French HR startup has raised 200m to go shopping across Europe. Paris-based Skello has raised 200m led by Bridgepoint, EU-Startups reports. The unusual part: its founders and managers came out owning more of the company, not less, as Tech Funding News [] This story continues at The Next Web
The korea Herald News
· Jun 23, 2026
[Bio USA] Korean biotechs bolster AstraZeneca partnership
SAN DIEGO — Korean biotechnology firms have advanced their partnerships with AstraZeneca, bolstering efforts toward open innovation and technological cooperation for eventual entrance into the global market. Under the name Project NOVA, the Korea Health Industry Development Institute on Monday held AstraZeneca partnering sessions for 13 Korean companies on the sidelines of the BIO International Convention taking place this week in San Diego. “We have a very good track record of doing excellent p
Irish Tech News
· Jun 23, 2026
AI infrastructure startup TensorX raises €8m
A team of Irish founders has committed 8 million to Nvidia Blackwell GPUs, including the latest B300 chips, to launch TensorX, a sovereign AI inference platform designed for Europe’s AI builders, trusted by regulated industries and already generating revenue from paying customers. The company was founded by Shane Morton, is part of the NVIDIA Inception []
The Motley Fool
· Jun 30, 2026
This Pharmaceutical Giant Just Poured $11 Billion on an Acquisition. Time to Buy?
AbbVie knows how to plan ahead.
Topics:
Related coverage for "Novo Nordisk’s owner backs an Italian fund to grow drug startups beyond Denmark": Foreign Policy Journal — Novo Nordisk (NYSE: NVO) Backs DKK 450 Million European Obesity Research Network While Pfizer Advances Monthly GLP-1 Therapy. The Next Web — Skello raises €200M and its founders end up owning more of the company. The korea Herald News — [Bio USA] Korean biotechs bolster AstraZeneca partnership. Irish Tech News — AI infrastructure startup TensorX raises €8m. The Motley Fool — This Pharmaceutical Giant Just Poured $11 Billion on an Acquisition. Time to Buy?